Diagnosis and Multidisciplinary Care of VHL Disease-Associated Tumors

Von Hippel-Lindau (VHL) disease is associated with a range of tumor types that require timely recognition and coordinated management. Accurate diagnosis depends on careful evaluation of clinical presentation, imaging findings, and genetic assessment, as these insights directly shape treatment decisions and long-term outcomes. Because patients with VHL disease often develop multiple tumor types across organ systems, care must extend beyond initial diagnosis to ongoing monitoring and planning for future VHL-associated manifestations. Deliver optimal patient-centered care requires seamless collaboration among specialists across disciplines. It is essential that clinicians are equipped with education on recognizing VHL-associated tumors and coordinating care across disciplines to improve early detection, treatment, and overall quality of life for affected patients In this CE Concepts BriefCase, expert faculty will discuss identifying patients with VHL disease associated tumors based on presentation, imaging, and genetic assessment as well as engaging an interdisciplinary team of professionals to guide management decisions. Through realistic clinician patient interactions and data-driven insights, this innovative format brings patient cases to life helping clinicians translate evidence into coordinated strategies that improve outcomes and quality of life for people with VHL.